Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario 12 de Octubre (19)

2023

  1. Identification of novel genetic loci for risk of multiple myeloma by functional annotation

    Leukemia

2021

  1. Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival

    International Journal of Cancer, Vol. 148, Núm. 8, pp. 1887-1894

  2. Polymorphisms within the TNFSF4 and mapkapk2 loci influence the risk of developing invasive aspergillosis: A two-stage case control study in the context of the aspbiomics consortium

    Journal of Fungi, Vol. 7, Núm. 1, pp. 1-17

2020

  1. Polymorphisms within the ARNT2 and CX3CR1 genes are associated with the risk of developing invasive aspergillosis

    Infection and Immunity, Vol. 88, Núm. 4

2017

  1. Identification of miRSNPs associated with the risk of multiple myeloma

    International Journal of Cancer, Vol. 140, Núm. 3, pp. 526-534

2016

  1. A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis

    Oncotarget, Vol. 7, Núm. 37, pp. 59029-59048

  2. Common genetic polymorphisms within NFκB-related genes and the risk of developing invasive aspergillosis

    Frontiers in Microbiology, Vol. 7, Núm. AUG

  3. Early mortality in multiple myeloma: the time-dependent impact of comorbidity: A population-based study in 621 real-life patients

    American Journal of Hematology, Vol. 91, Núm. 7, pp. 700-704

  4. Polymorphisms in host immunity-modulating genes and risk of invasive aspergillosis: Results from the AspBIOmics Consortium

    Infection and Immunity, Vol. 84, Núm. 3, pp. 643-657

2015

  1. Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients

    Nature Communications, Vol. 6

  2. Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length

    International Journal of Cancer, Vol. 136, Núm. 5, pp. E351-E358

  3. Type 2 diabetes-related variantsinfluence the risk of developing multiple myeloma: Results from the IMMEnSE consortium

    Endocrine-Related Cancer, Vol. 22, Núm. 4, pp. 545-559

2014

  1. Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations - An extensive replication of the associations from the candidate gene era

    Cancer Epidemiology Biomarkers and Prevention, Vol. 23, Núm. 4, pp. 670-674

2010

  1. Are elite endurance athletes genetically predisposed to lower disease risk?

    Physiological Genomics, Vol. 41, Núm. 1, pp. 82-90

  2. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

    Nature Genetics, Vol. 42, Núm. 5, pp. 426-429

2008

  1. Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification

    Journal of Pathology, Vol. 214, Núm. 3, pp. 347-356

2007

  1. Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer

    Oncogene, Vol. 26, Núm. 11, pp. 1616-1625

2006

  1. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy

    Journal of Clinical Oncology, Vol. 24, Núm. 26, pp. 4333-4339

2005

  1. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells

    Human Molecular Genetics, Vol. 14, Núm. 7, pp. 973-982